Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
291.00    18.40 (6.75%)
Bid:
289.20
Ask:
289.80
Spread: 0.60 (0.207%)
Market Cap: £733.28m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Director/PDMR Shareholding

20 Aug 2024 16:26

RNS Number : 1491B
Genuit Group PLC
20 August 2024
Β 

Genuit Group plc (the "Company")

The Company announces that on 15 August 2024, Joe Vorih, Chief Executive Officer and a Person Discharging Managerial Responsibilities, exercised a nil-cost option over 29,935 ordinary shares (including 9,163 dividend shares) of Β£0.001 each in the capital of the Company ("Shares") in accordance with the Deferred Share Award that was granted to him on 22 March 2022 (the "Award") which vested on 17 March 2024.

Full details of the Award were included in a regulatory announcement released on 23 March 2022 and in the Company's 2022 Annual Report and Accounts. The Company's Employee Benefit Trust has today transferred 15,866 Shares to Mr Vorih which represents the net number of Shares due to him after the appropriate tax and national insurance liabilities were taken into account.

The Company also announces that on 14 August 2024, Martin Gisbourne, Chief Strategy and Sustainability Officer and a Person Discharging Managerial Responsibilities, exercised a nil-cost option over 3,414 Shares in accordance with the Long-Term Incentive Plan award granted to him on 20 May 2021, which vested on 20 May 2024. Mr. Gisbourne sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

The notifications below, which have been made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Joe Vorih

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Executive Officer/Director and PDMR

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Genuit Group plc

b)

Β 

LEI

Β 

Β 

2138005IF1N2RKJ6KO18

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary shares of Β£0.001 each in the capital of Genuit Group plc

Β 

Β 

GB00BKRC5K31

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of ordinary shares

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Nil

Β 

15,866 - number of ordinary shares acquired after reduction for appropriate tax and national insurance liabilities.

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

N/A

Β 

Β 

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

15 August 2024

f)

Β 

Place of the transaction

Β 

Β 

Outside a trading venue

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Martin Gisbourne

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Strategy and Sustainability Officer and PDMR

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Genuit Group plc

b)

Β 

LEI

Β 

Β 

2138005IF1N2RKJ6KO18

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary shares of Β£0.001 each in the capital of Genuit Group plc

Β 

Β 

GB00BKRC5K31

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of ordinary shares for no consideration pursuant Β to the exercise of nil-cost options under the Long-Term Incentive Plan ("LTIP") award granted on 20 May 2021.

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Nil

Β 

1,739- Number of ordinary shares acquired after reduction for appropriate tax and national insurance

liabilities.

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

N/A

e)

Β 

Date of the transaction

Β 

Β 

16 August 2024

f)

Β 

Place of the transaction

Β 

Β 

Outside a Trading Venue

Β 

Enquiries:

Emma Versluys, Group Legal Counsel and Company Secretary

Β 

+44 (0) 1138 315 315

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHQKKBBPBKDPFB
Date   Source Headline
23rd Dec 20259:06 amRNSHolding(s) in Company
16th Dec 20252:03 pmRNSHolding(s) in Company
16th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20253:41 pmRNSDirector/PDMR Shareholding
10th Dec 20254:11 pmRNSDirector/PDMR Shareholding
9th Dec 202510:44 amRNSHolding(s) in Company
3rd Dec 20255:11 pmRNSHolding(s) in Company
3rd Dec 20254:56 pmRNSDirector/PDMR Shareholding
3rd Dec 20254:39 pmRNSDirector/PDMR Shareholding
3rd Dec 202510:00 amRNSHolding(s) in Company
2nd Dec 20255:09 pmRNSHolding(s) in Company
27th Nov 20254:49 pmRNSHolding(s) in Company
18th Nov 20254:28 pmRNSBlock Listing Application
18th Nov 20253:31 pmRNSDirector/PDMR Shareholding
17th Nov 20257:00 amRNSTrading Update
10th Nov 202511:40 amRNSHolding(s) in Company
7th Nov 20252:26 pmRNSHolding(s) in Company
3rd Nov 202510:00 amRNSBlock listing Interim Review
15th Oct 20251:30 pmRNSDirector/PDMR Shareholding
30th Sep 20253:51 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAcquisition of Davidson Holdings
18th Sep 20253:26 pmRNSDirectorate Change
1st Sep 20257:00 amRNSAcquisition of Monodraught
19th Aug 20256:11 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSHalf-year Report
26th Jun 20254:21 pmRNSDirector/PDMR Shareholding
20th Jun 20254:22 pmRNSDirectorate Change
19th May 20251:37 pmRNSResult of AGM
19th May 20257:00 amRNSTrading Statement
1st May 202512:26 pmRNSBlock listing Interim Review
15th Apr 20259:49 amRNSNotice of AGM
11th Mar 20257:00 amRNSFinal Results
21st Feb 20254:25 pmRNSHolding(s) in Company
14th Feb 20255:00 pmRNSHolding(s) in Company
28th Jan 202510:05 amRNSHolding(s) in Company
21st Jan 20251:53 pmRNSHolding(s) in Company
2nd Jan 202510:01 amRNSHolding(s) in Company
23rd Dec 20242:58 pmRNSHolding(s) in Company
19th Dec 20243:20 pmRNSDirector/PDMR Shareholding
17th Dec 202412:32 pmRNSHolding(s) in Company
12th Dec 20245:25 pmRNSHolding(s) in Company
25th Nov 20241:01 pmRNSDirector/PDMR Shareholding
19th Nov 20245:55 pmRNSHolding(s) in Company
19th Nov 20247:00 amRNSTrading Update
15th Nov 20243:10 pmRNSHolding(s) in Company
1st Nov 20241:37 pmRNSBlock listing Interim Review
31st Oct 20241:14 pmRNSHolding(s) in Company
11th Oct 202412:23 pmRNSHolding(s) in Company
7th Oct 20244:05 pmRNSHolding(s) in Company
9th Sep 20245:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.